BLACKSBURG, VA / ACCESS Newswire / March 18, 2026 / Built for engineers and designed by engineers who understand the realities of modern practice, Amber Book Continuing Education for Engineers was ...

RAS is mutated in nearly 20% of human cancers and has few direct, efficacious inhibitors. Here, we developed a synthetic protein, JAM20, to discover potential regions on RAS that may be used for ...